Difference between revisions of "Template:Regulation of therapeutic goods in the United States"

	Regulation of therapeutic goods in the United States
	File:Ritalin-SR-20mg-1000x1000.jpg
Law
	Federal Food, Drug, and Cosmetic Act; Comprehensive Drug Abuse Prevention and Control Act of 1970 ; Controlled Substances Act; Prescription Drug Marketing Act; Drug Price Competition and Patent Term Restoration Act; Hatch-Waxman exemption
Government agencies
	United States Department of Health and Human Services; Food and Drug Administration; Drug Enforcement Administration; Center for Drug Evaluation and Research
Process
	Drug discovery; Drug design; Drug development; New drug application; Investigational new drug; Clinical trial (Phase I, II, III, IV); Randomized controlled trial; Pharmacovigilance; Abbreviated New Drug Application; Fast track approval; Off-label use
International coordination
	International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use; Uppsala Monitoring Centre; World Health Organization; Council for International Organizations of Medical Sciences; Single Convention on Narcotic Drugs
Non-governmental organizations.
	Institute of Medicine; Research on Adverse Drug events And Reports
	v; d; e;

Latest revision as of 12:11, 19 September 2010

Revision as of 21:22, 8 January 2010 (view source) Mattgirling (Talk) (Reverted to revision 309308773 by 204.132.58.73; rm spam. (TW))	Latest revision as of 12:11, 19 September 2010 (view source) Jontas (Talk \| contribs) m (1 revision: Drug templates from wikipedia)
(No difference)